Emergent BioSolutions (EBS) EBIT (2011 - 2026)
Emergent BioSolutions (EBS) posted EBIT of -$125.1 million for Q2 2026, down 1291.43% on a QoQ basis from $10.5 million in Q1 2026, and down 7918.75% year-over-year from $1.6 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) EBIT (2011 - 2026) Analysis & Trends
Emergent BioSolutions has reported EBIT for 16 years, with the latest figure at -$125.1 million in Q2 2026.
- On a quarterly basis, EBIT fell 7918.75% year-over-year to -$125.1 million in Q2 2026; TTM through Jun 2026 was -$66.0 million, a 161.97% decrease from a year earlier, with the FY2025 full-year figure at $100.1 million, up 192.09% from the prior year.
- EBIT was -$125.1 million for Q2 2026 at Emergent BioSolutions, down from $10.5 million in the prior quarter.
- The five-year high for EBIT was $76.5 million in Q3 2025, with the low at -$292.9 million in Q2 2023.
- Average EBIT over 5 years is -$56.6 million, with a median of -$35.8 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2026: EBIT surged 126.96% in 2024, then slumped 7918.75% in 2026.
- Over 5 years, EBIT stood at -$55.3 million in 2022, then climbed by 20.8% to -$43.8 million in 2023, then jumped by 78.31% to -$9.5 million in 2024, then tumbled by 193.68% to -$27.9 million in 2025, then sank by 348.39% to -$125.1 million in 2026.
- The last three EBIT figures came in at -$125.1 million (Q2 2026), $10.5 million (Q1 2026), and -$27.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 4.27 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 360.00 Mn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | 1.22 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 325.05 Mn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | -505.13 Mn |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | -125.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -125.10 Mn |
| Mar 31, 2026 | 10.50 Mn |
| Dec 31, 2025 | -27.90 Mn |
| Sep 30, 2025 | 76.50 Mn |
| Jun 30, 2025 | 1.60 Mn |
| Mar 31, 2025 | 49.90 Mn |
| Dec 31, 2024 | -9.50 Mn |
| Sep 30, 2024 | 64.50 Mn |
| Jun 30, 2024 | -203.50 Mn |
| Mar 31, 2024 | 39.80 Mn |
| Dec 31, 2023 | -43.80 Mn |
| Sep 30, 2023 | -242.10 Mn |
| Jun 30, 2023 | -292.90 Mn |
| Mar 31, 2023 | -147.60 Mn |
| Dec 31, 2022 | -55.30 Mn |
| Sep 30, 2022 | -45.30 Mn |
| Jun 30, 2022 | -76.30 Mn |
| Mar 31, 2022 | 6.90 Mn |
| Dec 31, 2021 | 286.80 Mn |
| Sep 30, 2021 | -44.70 Mn |
API Access
Emergent BioSolutions EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();